Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Francisco Pedro Morais Dias De Almeida Sampaio

    Autor

  • Ricardo Manuel Alves Monteiro Fontes De Carvalho

    Autor

Participantes de fora da FMUP

  • Silva, G
  • Silva, M
  • Guerreiro, C
  • Pires-Morais, G
  • Santos, L
  • Melica, B
  • Rodrigues, A
  • Braga, P

Unidades de investigação

Abstract

Introduction and Objective: Coronary artery disease is highly prevalent among patients with severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVR). As indications for TAVR are now expanding to younger and lower-risk patients, the need for coronary angiography (CA) and percutaneous coronary intervention (PCI) during their lifetime is expected to increase. The objective of our study was to assess the need for CA and the feasibility of re-engaging the coronary ostia after TAVR.Methods: We performed a retrospective analysis of 853 consecutive patients undergoing TAVR between August 2007 and December 2020. Patients who needed CA after TAVR were selected. The primary endpoint was the rate of successful coronary ostia cannulation after TAVR.Results: Of a total of 31 CAs in 28 patients (3.5% of 810 patients analyzed: 57% male, age 77.8 & PLUSMN;7.0 years) performed after TAVR, 28 (90%) met the primary endpoint and in three cannulation was semi-selective. All failed selective coronary ostia cannulations occurred in patients with a self-expanding valve. Sixteen (52%) also had indication for PCI, which was successfully performed in all. The main indication for CA was non-ST-elevation acute coronary syndrome (35%, n=11). Two cases of primary PCI occurred without delay. There were no complications reported during or after the procedure.Conclusion: Although CA was rarely needed in patients after TAVR, selective diagnostic CA was possible in the overwhelming majority of patients. PCI was performed successfully in all cases, without complications.& COPY; 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan & SIM;a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Dados da publicação

ISSN/ISSNe:
0870-2551, 2174-2030

Revista Portuguesa de Cardiologia  Sociedade Portuguesa De Cardiologia

Tipo:
Article
Páginas:
749-756
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Aortic valve disease; Coronary angiography; Coronary artery disease; Percutaneous coronary intervention; Transcatheter aortic valve replacement

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846

Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes

Estudo Observacional Académico (F-CHECK) . Sanofi . 2022

The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (Obesity) . 2020

Suboptimal control of cardiovascular risk factors in myocardial infarction survivors

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (myocard) . 2020

Impacto dos acessos femorais guiados por ecografia vs fluoroscopia nas complicações vasculares associadas à implantação de válvula aórtica percutânea

Investigador Principal: Francisco Pedro Morais Dias de Almeida Sampaio

Estudo Clínico Académico . 2021

Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação